(CSWC) Amundi MSCI Switzerland - Ratings and Ratios
Swiss Stocks, Large Cap, Equities, Switzerland Equity
Description: CSWC Amundi MSCI Switzerland
Amundi MSCI Switzerland UCITS is an ETF that tracks the Morningstar Switzerland TME NR CHF index, providing exposure to the Swiss equity market. As a Switzerland Equity ETF, it is designed to capture the performance of the Swiss market.
With Assets Under Management (AUM) of 230.65M CHF, the fund has a moderate size, indicating a reasonable level of liquidity. The ETFs trading activity can be considered stable, given its listing on a major exchange and the presence of market makers.
To evaluate the ETFs performance, we can look at its tracking error, which measures the deviation of the ETFs returns from its underlying index. Although not provided, a low tracking error is expected for a well-established ETF like Amundi MSCI Switzerland UCITS. Key Performance Indicators (KPIs) to monitor include the ETFs expense ratio, which is likely to be competitive given Amundis reputation as a low-cost provider, and its trading volume, which should be sufficient to support efficient execution.
From a technical analysis perspective, the ETFs price is currently near its SMA20 and SMA200, indicating a relatively stable trend. The Average True Range (ATR) of 0.08 (0.75%) suggests moderate volatility, which is expected for an equity ETF. To further assess the ETFs attractiveness, we can examine its historical returns, Sharpe ratio, and other risk-adjusted metrics to determine its potential for long-term growth and risk management.
Additional Sources for CSWC ETF
CSWC ETF Overview
Market Cap in USD | 287m |
Category | Switzerland Equity |
TER | 0.25% |
IPO / Inception | 2018-03-22 |
CSWC ETF Ratings
Growth Rating | 32.0 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -12.6 |
Analysts | - |
Fair Price Momentum | 9.97 CHF |
Fair Price DCF | - |
CSWC Dividends
Currently no dividends paidCSWC Growth Ratios
Growth Correlation 3m | -2.2% |
Growth Correlation 12m | 37.6% |
Growth Correlation 5y | 55.9% |
CAGR 5y | 4.73% |
CAGR/Max DD 5y | 0.21 |
Sharpe Ratio 12m | 0.46 |
Alpha | -6.34 |
Beta | 0.480 |
Volatility | 9.68% |
Current Volume | 20k |
Average Volume 20d | 0.6k |
Stop Loss | 10.5 (-3.4%) |
As of July 18, 2025, the stock is trading at CHF 10.87 with a total of 20,030 shares traded.
Over the past week, the price has changed by -0.73%, over one month by -1.16%, over three months by +4.60% and over the past year by -0.51%.
Neither. Based on ValueRay´s Analyses, Amundi MSCI Switzerland is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 32.03 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CSWC is around 9.97 CHF . This means that CSWC is currently overvalued and has a potential downside of -8.28%.
Amundi MSCI Switzerland has no consensus analysts rating.
According to our own proprietary Forecast Model, CSWC Amundi MSCI Switzerland will be worth about 11.1 in July 2026. The stock is currently trading at 10.87. This means that the stock has a potential upside of +2.02%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 11.1 | 2% |